Extracellular nucleic acid-triggered precision responsive antibacterial strategy

Area of Science:

• Biotechnology
• Molecular Biology
• Antimicrobial Research

Background:

• Antibiotic resistance poses a significant global health threat, necessitating innovative treatment strategies.
• Current antibacterial approaches often lack specificity, leading to off-target effects and reduced efficacy.
• There is an urgent need for precision-targeted therapies to combat resistant bacterial infections.

Purpose of the Study:

• To design and validate a novel responsive antibacterial system for precise bacterial eradication.
• To develop a system where drug release is specifically triggered by extracellular nucleic acids.
• To ensure highly specific and quantitative drug release for targeted antibacterial action.

Main Methods:

• Conjugation of antibacterial agents to nucleic acid probes.
• Utilizing toehold-mediated strand displacement for single-nucleotide precision targeting.
• Employing bacterial growth inhibition curves, inhibition zone measurements, and fluorescence staining assays for evaluation.

Main Results:

• Demonstrated exceptional stability and selectivity of the designed antibacterial system.
• Validated the system's efficacy in spiked environmental water samples, confirming real-world applicability.
• Achieved precise bacterial targeting and quantitative drug release triggered by extracellular nucleic acids.

Conclusions:

• The novel antibacterial strategy exhibits excellent stability and selectivity.
• The system effectively targets and eliminates bacteria in simulated environmental conditions.
• This approach offers a promising solution for combating antibiotic-resistant bacteria.